meddevicedb.com FDA Device Reference

Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Strip, Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Cassette, Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Midstream

K213808 Class II Special
Decision Date
2022-04-05
Sponsor / Applicant
Co-Innovation Biotech Co., Ltd.

Technical Specification

510(k) Submission ID K213808
Product Code LCX
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1155
Decision Date 2022-04-05
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Strip, Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Cassette, Co-Innovation One Step Human Chorionic Gonadotropin (HCG) Test Midstream received FDA 510(k) clearance under submission number K213808, sponsored by Co-Innovation Biotech Co., Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2022-04-05.

Classification & Regulation

This clearance is catalogued under FDA product code LCX and 21 CFR 862.1155, within the Clinical Chemistry review panel as a Class II device.